We suggest therefore that the behavior of EC at atheroprone sites is a reflection of an early developmental stage and that developmental genes including GATA4 and TWIST1 could be novel therapeutic targets in atherosclerosis. This evidence concerns the gene TWIST1 and atherosclerosis.